Takeda Pharmaceutical Co., Ltd. (TAK)
18.14
+0.32
(+1.82%)
USD |
NYSE |
Oct 06, 12:16
Takeda Pharmaceutical Price : 18.14 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 17.78 | 17.91 | 17.75 | 17.81 | 3.405M |
| Oct 02, 2026 | 17.85 | 17.89 | 17.78 | 17.86 | 2.133M |
| Oct 01, 2026 | 18.07 | 18.13 | 17.86 | 17.86 | 2.404M |
| Sep 30, 2026 | 18.46 | 18.46 | 18.18 | 18.19 | 2.103M |
| Sep 29, 2026 | 18.56 | 18.58 | 18.37 | 18.51 | 2.415M |
| Sep 28, 2026 | 18.76 | 19.00 | 18.64 | 18.90 | 2.063M |
| Sep 25, 2026 | 18.82 | 18.91 | 18.76 | 18.86 | 2.738M |
| Sep 24, 2026 | 18.55 | 18.74 | 18.51 | 18.59 | 3.257M |
| Sep 23, 2026 | 18.86 | 18.98 | 18.78 | 18.81 | 2.606M |
| Sep 22, 2026 | 18.92 | 19.04 | 18.81 | 18.95 | 1.404M |
| Sep 21, 2026 | 18.98 | 18.99 | 18.84 | 18.89 | 1.756M |
| Sep 18, 2026 | 18.80 | 19.01 | 18.80 | 18.91 | 2.961M |
| Sep 17, 2026 | 19.02 | 19.10 | 19.00 | 19.05 | 2.711M |
| Sep 16, 2026 | 18.75 | 18.82 | 18.60 | 18.64 | 2.952M |
| Sep 15, 2026 | 18.74 | 18.76 | 18.61 | 18.70 | 2.678M |
| Sep 14, 2026 | 18.56 | 18.70 | 18.54 | 18.60 | 2.358M |
| Sep 11, 2026 | 18.38 | 18.44 | 18.20 | 18.26 | 2.150M |
| Sep 10, 2026 | 18.34 | 18.34 | 18.10 | 18.11 | 1.749M |
| Sep 09, 2026 | 18.18 | 18.35 | 18.15 | 18.21 | 1.565M |
| Sep 08, 2026 | 18.53 | 18.65 | 18.28 | 18.32 | 3.139M |
| Sep 04, 2026 | 18.48 | 18.54 | 18.38 | 18.45 | 1.500M |
| Sep 03, 2026 | 18.75 | 18.84 | 18.52 | 18.71 | 2.854M |
| Sep 02, 2026 | 18.30 | 18.50 | 18.28 | 18.43 | 1.722M |
| Sep 01, 2026 | 18.18 | 18.40 | 18.18 | 18.23 | 1.899M |
| Aug 31, 2026 | 17.99 | 18.06 | 17.96 | 17.98 | 1.780M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sanofi | 39.70 |
| Daiichi Sankyo Co., Ltd. | 17.37 |
| Ono Pharmaceutical Co., Ltd. | 4.78 |
| Astellas Pharma, Inc. | 14.21 |
| Eisai Co., Ltd. | 7.41 |
Price Related Metrics
| PS Ratio | 1.930 |
| Price to Book Value | 1.233 |
| Price to Free Cash Flow | 21.49 |
| Earnings Yield | -1.86% |
| Market Cap | 57.32B |
| Operating PE Ratio | 12.63 |